According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -0,50 โฌ. In 2022 the company made an earnings per share (EPS) of -0,92 โฌ a decrease over its 2021 EPS that were of -0,75 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -0,49 โฌ | -46.81% |
2022 | -0,92 โฌ | 22.08% |
2021 | -0,75 โฌ | 16.67% |
2020 | -0,65 โฌ | -8.33% |
2019 | -0,70 โฌ | -22.58% |
2018 | -0,91 โฌ | 20.78% |
2017 | -0,75 โฌ | -10.47% |
2016 | -0,84 โฌ | 22.86% |
2015 | -0,68 โฌ | 6.06% |
2014 | -0,65 โฌ | 13.79% |
2013 | -0,57 โฌ | -7.94% |
2012 | -0,62 โฌ | |
2011 | N/A | -100% |
2010 | -0,59 โฌ | 25% |
2009 | -0,47 โฌ | -50% |
2008 | -0,94 โฌ | -11.11% |
2007 | -1,06 โฌ | 668.73% |
2006 | -0,14 โฌ |